JP2024518413A - 修飾ヌクレアーゼ - Google Patents

修飾ヌクレアーゼ Download PDF

Info

Publication number
JP2024518413A
JP2024518413A JP2023568340A JP2023568340A JP2024518413A JP 2024518413 A JP2024518413 A JP 2024518413A JP 2023568340 A JP2023568340 A JP 2023568340A JP 2023568340 A JP2023568340 A JP 2023568340A JP 2024518413 A JP2024518413 A JP 2024518413A
Authority
JP
Japan
Prior art keywords
composition
seq
sequence
cell
nls
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023568340A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022236147A5 (https=
JP2024518413A5 (https=
Inventor
ローランド バウムガートナー
ターニャ ワルネッケ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Artisan Development Labs Inc
Original Assignee
Artisan Development Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Artisan Development Labs Inc filed Critical Artisan Development Labs Inc
Publication of JP2024518413A publication Critical patent/JP2024518413A/ja
Publication of JPWO2022236147A5 publication Critical patent/JPWO2022236147A5/ja
Publication of JP2024518413A5 publication Critical patent/JP2024518413A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C12N9/222Clustered regularly interspaced short palindromic repeats [CRISPR]-associated [CAS] enzymes
    • C12N9/226Class 2 CAS enzyme complex, e.g. single CAS protein
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/20Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2023568340A 2021-05-06 2022-05-06 修飾ヌクレアーゼ Pending JP2024518413A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163185315P 2021-05-06 2021-05-06
US63/185,315 2021-05-06
US202263315483P 2022-03-01 2022-03-01
US63/315,483 2022-03-01
PCT/US2022/028208 WO2022236147A1 (en) 2021-05-06 2022-05-06 Modified nucleases

Publications (3)

Publication Number Publication Date
JP2024518413A true JP2024518413A (ja) 2024-05-01
JPWO2022236147A5 JPWO2022236147A5 (https=) 2025-05-13
JP2024518413A5 JP2024518413A5 (https=) 2025-05-13

Family

ID=81975392

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023568340A Pending JP2024518413A (ja) 2021-05-06 2022-05-06 修飾ヌクレアーゼ

Country Status (4)

Country Link
US (2) US20260009009A1 (https=)
JP (1) JP2024518413A (https=)
CA (1) CA3218053A1 (https=)
WO (1) WO2022236147A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2024007790A (es) 2021-12-22 2024-09-06 Camp4 Therapeutics Corp Modulación de la transcripción génica utilizando oligonucleótidos antisentido dirigidos a arn reguladores.
IL324634A (en) 2023-05-15 2026-01-01 Nchroma Bio Inc Compositions and methods for epigenetic regulation of hbv gene expression
WO2026046724A1 (en) * 2024-08-30 2026-03-05 Cellectis Sa Tale protein scaffolds involving fusions of monopartite and bipartite nls

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020109412A1 (en) * 2018-11-28 2020-06-04 Keygene N.V. Targeted enrichment by endonuclease protection
JP2020530264A (ja) * 2017-06-23 2020-10-22 インスクリプタ, インコーポレイテッド 核酸誘導型ヌクレアーゼ
US20200354703A1 (en) * 2018-10-22 2020-11-12 Inscripta, Inc. Engineered enzymes
WO2021067788A1 (en) * 2019-10-03 2021-04-08 Artisan Development Labs, Inc. Crispr systems with engineered dual guide nucleic acids

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
WO2017106569A1 (en) * 2015-12-18 2017-06-22 The Regents Of The University Of California Modified site-directed modifying polypeptides and methods of use thereof
US9896696B2 (en) 2016-02-15 2018-02-20 Benson Hill Biosystems, Inc. Compositions and methods for modifying genomes
US9982279B1 (en) 2017-06-23 2018-05-29 Inscripta, Inc. Nucleic acid-guided nucleases
US10011849B1 (en) * 2017-06-23 2018-07-03 Inscripta, Inc. Nucleic acid-guided nucleases
US11649442B2 (en) * 2017-09-08 2023-05-16 The Regents Of The University Of California RNA-guided endonuclease fusion polypeptides and methods of use thereof
WO2019118516A1 (en) * 2017-12-11 2019-06-20 Editas Medicine, Inc. Cpf1-related methods and compositions for gene editing
EP3821008A1 (en) * 2018-07-12 2021-05-19 Keygene N.V. Type v crispr/nuclease-system for genome editing in plant cells
WO2020092057A1 (en) * 2018-10-30 2020-05-07 Yale University Compositions and methods for rapid and modular generation of chimeric antigen receptor t cells
CN113039278A (zh) * 2018-10-31 2021-06-25 诺维信公司 通过指导的内切核酸酶和单链寡核苷酸进行基因组编辑
CA3153700A1 (en) * 2019-09-09 2021-03-18 Scribe Therapeutics Inc. Compositions and methods for use in immunotherapy
US20230348869A1 (en) * 2019-10-14 2023-11-02 KWS SAAT SE & Co. KGaA Mad7 nuclease in plants and expanding its pam recognition capability
CA3166430A1 (en) 2020-02-05 2021-08-12 Ryan T. Gill Compositions and methods for targeting, editing or modifying human genes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020530264A (ja) * 2017-06-23 2020-10-22 インスクリプタ, インコーポレイテッド 核酸誘導型ヌクレアーゼ
US20200354703A1 (en) * 2018-10-22 2020-11-12 Inscripta, Inc. Engineered enzymes
WO2020109412A1 (en) * 2018-11-28 2020-06-04 Keygene N.V. Targeted enrichment by endonuclease protection
WO2021067788A1 (en) * 2019-10-03 2021-04-08 Artisan Development Labs, Inc. Crispr systems with engineered dual guide nucleic acids

Also Published As

Publication number Publication date
US20230340437A1 (en) 2023-10-26
US20260009009A1 (en) 2026-01-08
CA3218053A1 (en) 2022-11-10
WO2022236147A1 (en) 2022-11-10

Similar Documents

Publication Publication Date Title
CN115698278B (zh) 包含Cas12i2变体多肽的组合物及其用途
KR102666695B1 (ko) Rna를 편집하기 위한 방법 및 조성물
KR102851101B1 (ko) Rna를 편집하기 위한 방법 및 조성물
US11667903B2 (en) Tracking and manipulating cellular RNA via nuclear delivery of CRISPR/CAS9
CA3036926C (en) Modified stem cell memory t cells, methods of making and methods of using same
US20230340437A1 (en) Modified nucleases
AU2020358863A1 (en) CRISPR systems with engineered dual guide nucleic acids
EP4388105A1 (en) Persistent allogeneic modified immune cells and methods of use thereof
US20250179481A1 (en) Compositions and methods for targeting, editing, or modifying genes
JP2024501892A (ja) 新規の核酸誘導型ヌクレアーゼ
US20250115903A1 (en) Compositions and methods for editing genomes
US20250388896A1 (en) Composition and methods for transgene insertion
HK40081918B (en) Methods and compositions for editing rna
WO2025259791A1 (en) Compositions and methods for tnpb and ωrna mediated targeting
WO2026083309A1 (en) Use of inhibitors or modulators of artemis in gene editing
HK40081918A (en) Methods and compositions for editing rna
KR20250021340A (ko) 유전자 및 세포 치료를 위한 tale 염기 편집기
EP4601650A2 (en) Compositions and methods for targeting, editing, or modifying genes
CN117136233A (zh) 包含变体Cas12i4多肽的组合物及其用途
HK40061041A (en) Methods and compositions for editing rnas
HK40056042A (en) Methods and compositions for editing rnas
HK40056042B (en) Methods and compositions for editing rnas

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250501

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250501

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260217